Grow Therapy logo

Grow Therapy IPO

Grow Therapy operates a digital platform that connects patients with licensed therapists for mental health services. The company has grown rapidly by addressing the shortage of accessible mental health care and streamlining the therapist-patient matching process. Investors are interested in its IPO potential due to the expanding telehealth market and increasing demand for mental health services.

No IPO AnnouncedUpdated April 2, 2026

Key Facts

IndustryHealthcare Technology
Founded2021
HeadquartersNew York, NY
Employees~500
Websitegrowtherapy.com
FundingSeries B at $3B valuation. Total raised: $158M

About Grow Therapy

Grow Therapy is a mental health platform that connects patients with licensed therapists while handling insurance billing and administrative tasks for providers. Unlike many telehealth platforms that focus on direct-pay models, Grow Therapy specifically works to make therapy accessible through insurance coverage, addressing a major barrier to mental healthcare access. The platform provides therapists with tools for practice management, scheduling, and documentation.

The company has rapidly scaled by focusing on the provider experience, offering therapists higher reimbursement rates and reducing administrative burden compared to traditional practice models. Grow Therapy's approach of building a network of in-network providers differentiates it from competitors that primarily offer out-of-network or subscription-based services, potentially making it more sustainable long-term as insurance coverage for mental health continues to expand.

IPO Status

Grow Therapy has not announced any plans for an initial public offering. The company has raised significant venture capital funding to expand its mental health platform, but has remained private since its founding. As a growing player in the competitive telehealth and mental health services market, Grow Therapy could be a candidate for future public markets consideration. However, no confirmed details about IPO timing, valuation targets, or underwriter selection have been disclosed. The company appears focused on scaling its operations and user base in the private markets for now.

Competitors

Frequently Asked Questions

Does Grow Therapy have a stock?

No, Grow Therapy has not had an IPO and remains a private company. The company has not announced any plans to go public at this time.

When is the Grow Therapy IPO date?

There is no confirmed IPO date for Grow Therapy, as the company has not announced plans to go public. Any timeline for a potential offering remains speculative.

How can I buy Grow Therapy stock?

Grow Therapy stock is not currently available for purchase as the company is privately held. If the company decides to go public in the future, shares would become available through brokers.

Stay Updated on the Grow Therapy IPO

Get real-time alerts when Grow Therapy files for an IPO, prices shares, or begins trading.

Get IPO Alerts

Related IPOs